— Know what they know.
Not Investment Advice
Also trades as: AQS.V (TSXV) · $vol 0M

AQSZF OTC

Aequus Pharmaceuticals Inc.
1W: +0.0% 1M: +0.0% 3M: -73.1% YTD: -41.7% 1Y: -66.7% 3Y: -96.5% 5Y: -99.4%
$0.00
+0.00 (+0.00%)
 
OTC · Healthcare · Drug Manufacturers - Specialty & Generic · Tech Score Neutral · Power 52 · $92844 mcap · 113M float · 0.037% daily turnover · Short 56% of daily vol

Balance Sheet Trends

Total Assets
$800K -26.3% ▼
5Y CAGR: -13.7%
Total Liabilities
$7M +34.9% ▲
5Y CAGR: +23.3%
Shareholders Equity
-$6M -50.3% ▼
Cash & Investments
$50K -70.5% ▼
5Y CAGR: -36.4%
Total Debt
$7M +30.6% ▲
5Y CAGR: +24.4%
Net Debt
$7M +34.1% ▲

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2020FY2021FY2022FY2023FY2024
— Assets —
Cash$2M$2M$250K$170K$50K
Short-Term Investments$0$45K$0$0$0
Cash & ST Investments$2M$2M$250K$170K$50K
Net Receivables$780K$941K$310K$32K$58K
Inventory$123K$140K$94K$124K$38K
Other Current Assets$0$0$45K$45K$0
Total Current Assets$3M$4M$903K$436K$282K
Property, Plant & Equip.$366K$242K$789K$651K$518K
Goodwill & Intangibles$0$0$0$0$0
Long-Term Investments$0$0$0$0$0
Other Non-Current Assets$0$513K$0$0$0
Total Non-Current Assets$366K$755K$789K$651K$518K
Total Assets$3M$4M$2M$1M$800K
— Liabilities —
Accounts Payable$161K$157K$88K$274K$543K
Short-Term Debt$0$2M$2M$4M$6M
Deferred Revenue$0$0$0$0$0
Other Current Liabilities$0$0$0$0$0
Total Current Liabilities$384K$2M$2M$5M$7M
Long-Term Debt$2M$26K$0$0$0
Other Non-Current Liab.$0$0$0$0$0
Total Non-Current Liabilities$2M$102K$694K$584K$459K
Total Liabilities$3M$3M$3M$5M$7M
— Equity —
Common Stock$21M$24M$24M$24M$24M
Retained Earnings-$25M-$27M-$30M-$33M-$35M
Accumulated OCI$4M$4M$4M$4M$4M
Total Stockholders Equity$574K$2M-$1M-$4M-$6M
Total Liabilities & Equity$3M$4M$2M$1M$800K
— Key Metrics —
Total Debt$2M$2M$3M$5M$7M
Net Debt$605K-$211K$3M$5M$7M
Total Investments$0$45K$0$0$0

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms